Two South African brothers sell R640 million in shares after inheriting a pharmaceutical empire

 ·18 Mar 2026

Mark and Dan Saltzman, the sons of Dis-Chem founders Lynette and Ivan Saltzman, have sold shares in the company for over R600 million.

The brothers each sold shares worth roughly R321 million from January to February of this year.

The brothers both received shares in the company worth billions in June 2025 following a major shift in the family’s holding structure.

The brothers received 217 million in shares in the company last year, which represented around a quarter of the JSE-listed company that was founded by their parents in 1978.

Prior to the shift, the family’s investment vehicle, Ivlyn, held a 29% stake in the company. Following the change, Ivlyn’s interest has decreased substantially to around 4%.

The brothers each received around a 12.5% beneficial interest in the company, after having none previously.

While Mark and Dan did not hold executive or board roles when they received the shares, their other brother, Saul, did work at the group as an Executive Director at the time.

However, after 19 years as a director, Saul resigned from the role, effective 27 February 2026. He is still on the board as a non-independent non-executive director.

This coincides with a major change in Ivan’s role, who left his position as Dis-Chem Group CEO in 2023. He was succeeded by Rui Morais, formerly the company’s CFO. 

While Ivan still worked as an executive director after leaving the CEO role, the company recently announced that he would also step down from that position.

Ivan will step down as an executive director of the company in June 2026, but will continue to work as a Non-Executive Director and Deputy Chairman of the group. 

Dis-Chem said that Ivan had played a pivotal role in growing and transforming the company from its early beginnings as a family-owned business into a JSE-listed retail giant.

Lynette had already stepped down from her role as an executive director in 2022 to focus on an operational role within the group’s beauty category.

The details of the recent share sales by Mark and Dan Saltzman can be found below:


Mark Saltzman Share Sales

Number of SecuritiesPrice per SecurityValue of TransactionDate of Transaction
57 789R35,68R2 062 131,122026/01/06
1 350 000R35,60R48 060 000,002026/01/06
40 812R36,06R1 471 872,542026/01/09
2 750 000R36,00R99 000 000,002026/01/09
92 613R36,50R3 380 504,162026/01/30
90 551R36,51R3 306 306,682026/02/02
498 762R36,50R18 204 813,002026/02/02
35 208R36,59R1 288 376,912026/02/03
128 348R36,50R4 684 702,002026/02/09
21 338R36,50R778 837,002026/02/10
221 616R36,50R8 089 138,912026/02/11
15 063R36,50R549 799,502026/02/12
73 063R36,50R2 666 996,702026/02/16
122 279R36,50R4 463 696,952026/02/17
481 095R36,63R17 622 268,822026/02/18
102 646R36,61R3 758 331,972026/02/19
530 000R37,57R19 910 563,002026/02/20
243 672R37,55R9 149 298,792026/02/23
123 201R36,74R4 526 798,862026/02/24
181 569R37,00R6 718 053,002026/02/25
999 560R37,00R36 983 720,002026/02/26
660 994R37,00R24 456 778,002026/02/27
8 820 179R321 132 987,91

Dan Saltzman Share Sales

Number of SecuritiesPrice per SecurityValue of TransactionDate of Transaction
57 789R35,68R2 062 131,122026/01/06
1 350 000R35,60R48 060 000,002026/01/06
40 812R36,06R1 471 872,542026/01/09
2 750 000R36,00R99 000 000,002026/01/09
92 613R36,50R3 380 504,162026/01/30
90 552R36,51R3 306 343,292026/02/02
498 761R36,50R18 204 776,502026/02/02
35 208R36,59R1 288 376,912026/02/03
128 348R36,50R4 684 702,002026/02/09
21 337R36,50R778 800,502026/02/10
221 616R36,50R8 089 138,912026/02/11
15 063R36,50R549 799,502026/02/12
73 064R36,50R2 667 033,202026/02/16
122 279R36,50R4 463 696,952026/02/17
481 095R36,63R17 622 268,822026/02/18
102 645R36,61R3 758 295,252026/02/19
530 000R37,57R19 910 563,002026/02/20
243 673R37,55R9 149 336,092026/02/23
123 200R36,74R4 526 762,242026/02/24
181 570R37,00R6 718 090,002026/02/25
999 559R37,00R36 983 683,002026/02/26
660 994R37,00R24 456 778,002026/02/27
8 820 178R321 132 951,98

Show comments
Subscribe to our daily newsletter